Bortezomib will boost the stage or effect of flibanserin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Enhanced flibanserin adverse consequences could manifest if coadministered with a number of weak CYP3A4 inhibitors. lenacapavir will increase the stage or effect of bortezomib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep ... https://altonv100jsf3.weblogco.com/profile